Accelerate the development of
genetic therapies aimed at curing sickle cell disease.
The Cure Sickle Cell Initiative was created by the
National Heart, Lung, and Blood Institute to:
- Use emerging safe and promising genetic therapies to improve the lives of individuals with sickle cell disease.
- Actively engage the sickle cell disease community of patients, family members, caregivers and advocates to work together on a path to the cure.
- Encourage collaboration among researchers, industry, non-profit organizations, and policy-making agencies who will play a role in curing the disease.